# Plant Monograph: Cinchona Bark
**Name of plant:**
Cinchona Bark
**Catch phrase (Carmina Gadelica or traditional invocation if available):**
No traditional Carmina Gadelica invocation is recorded for cinchona. A historical phrase often associated with the plant is: **“The bark that conquered the fever.”**
**Family:**
Rubiaceae — Madder family
**Genus and species:**
*Cinchona officinalis* L., *Cinchona calisaya* Wedd., *Cinchona ledgeriana* Moens ex Trimen, and related *Cinchona* species
**Other names:**
Cinchona, Peruvian bark, Jesuit's bark, Jesuits' powder, Countess's powder, fever tree, quinine bark, China bark, Jesuit bark, red cinchona, yellow cinchona, crown bark.
**Brief introduction:**
Cinchona is a genus of evergreen trees native to the Andean forests of South America, particularly Peru, Ecuador, Bolivia, and Colombia. The medicinal bark contains quinoline alkaloids, most notably quinine, which revolutionized the treatment of malaria and transformed global medicine. For centuries, cinchona bark was one of the world's most valuable medicinal commodities, playing a crucial role in tropical medicine and enabling European expansion into malaria-endemic regions. Today, cinchona remains historically significant as the natural source of quinine and related alkaloids.
**Traditional uses:**
* Used for intermittent fevers and malaria-like illnesses.
* Employed as a bitter digestive tonic.
* Traditionally used to stimulate appetite.
* Used for weakness and convalescence following illness.
* Administered for various febrile infectious diseases.
**Historical use:**
* Used by Indigenous peoples of the Andes for fevers and chills.
* Introduced to European medicine during the seventeenth century.
* Became the primary treatment for malaria worldwide before modern antimalarial drugs.
* Played a major role in military and colonial medicine in tropical regions.
* Led to the isolation of quinine in 1820, one of the landmark discoveries in pharmacology.
**Parts used and method of use:**
* Bark
* Dried stem bark and trunk bark
Used as:
* Decoction.
* Powdered bark.
* Tincture or fluid extract.
* Source material for quinine extraction.
**Use in healing (modern herbal practice):**
* Bitter digestive stimulant.
* Appetite-supportive herb.
* Historically significant antimalarial agent.
* Occasionally included in traditional bitter tonic formulas.
* Source of pharmacologically important alkaloids.
**Pharmacology and biochemistry:**
* **Quinine** — the most famous cinchona alkaloid.
* **Quinidine** — antiarrhythmic alkaloid.
* **Cinchonine and cinchonidine** — related quinoline alkaloids.
**Mechanisms:**
* Quinine interferes with the malaria parasite's ability to metabolize heme within infected red blood cells.
* Bitter alkaloids stimulate digestive secretions through activation of bitter taste receptors.
* Quinidine affects cardiac electrical conduction and myocardial excitability.
**Overall profile:**
Cinchona bark is one of the most historically important medicinal plants ever discovered. Its quinoline alkaloids transformed medicine by providing an effective treatment for malaria centuries before modern antibiotics or synthetic pharmaceuticals. While the bark retains value as a bitter digestive tonic, its primary significance today lies in its contribution to pharmacology and the development of modern antimalarial therapies.
**Common dosage:**
* **Traditional decoction:** Historically 1–4 g dried bark daily depending on alkaloid content.
* **Powdered bark:** Historically 500 mg–2 g daily under professional supervision.
* **Tincture (1:5):** 1–4 mL up to three times daily.
* **Modern medicinal use:** Quinine dosing follows pharmaceutical standards and medical supervision rather than herbal dosage recommendations.
Because alkaloid concentrations vary considerably, medicinal use of cinchona bark should follow professional guidance and pharmacopoeial standards.
**Safety factors (including side effects):**
* Excessive use may cause cinchonism, characterized by tinnitus, headache, nausea, dizziness, and visual disturbances.
* May cause serious cardiac effects in susceptible individuals.
* Can provoke hypersensitivity reactions.
* Contraindicated in individuals with known quinine sensitivity.
* Long-term or excessive use carries substantially greater risk than most common medicinal herbs.
**First aid / adverse reaction response:**
* **Mild nausea, headache, or dizziness:** Discontinue use and monitor symptoms.
* **Tinnitus, hearing changes, or visual disturbances:** Stop use and seek medical evaluation promptly.
* **Cardiac symptoms (palpitations, irregular heartbeat):** Seek immediate medical attention.
* **Severe allergic reaction (swelling, breathing difficulty, anaphylaxis):** Seek emergency medical treatment immediately.
**Drug interactions:**
* Significant interactions may occur with antiarrhythmic medications.
* May interact with anticoagulants and antiplatelet medications.
* Can interact with drugs affecting cardiac conduction or QT interval.
* Due to the pharmacological potency of quinine alkaloids, professional supervision is advised whenever cinchona preparations are used medicinally.
**Horticultural requirements:**
* USDA / Canadian zone: Zones 10–12.
* Soil pH: Approximately 5.5–7.0.
* Light requirements: Partial shade to full sun in tropical climates.
* Moisture: High; prefers humid conditions and consistent rainfall.
* Other notes (growth habit, harvest timing, etc.):
* **Growth habit:** Evergreen tree reaching 5–20 m or more in height.
* **Flowering/fruiting:** Produces clusters of fragrant white, pink, or reddish flowers followed by capsule fruits.
* **Harvest timing:** Bark is harvested from mature trees after several years of growth.
* **Habitat:** Montane tropical forests of the Andes at elevations typically between 1,000 and 3,000 m.
* **Propagation/cultivation notes:** Cultivated historically in South America, India, Sri Lanka, Indonesia, and Africa for quinine production. Commercial cultivation largely shifted to plantation systems during the nineteenth and twentieth centuries.
**Sampling of clinical reports / studies:**
* **Clinical study or report:** Historical clinical evidence for quinine's effectiveness against malaria is among the strongest in the history of herbal medicine and predates modern clinical trial methodology.
* **Pharmacological study:** Extensive research has characterized quinine, quinidine, cinchonine, and related alkaloids, leading to major advances in parasitology, cardiology, and pharmacology.
* **Phytochemical study:** Studies consistently identify quinoline alkaloids as the principal medicinal constituents, alongside tannins and minor polyphenolic compounds.
* **Ethnobotanical evidence:** Indigenous Andean use, followed by centuries of global medicinal application, provide one of the richest ethnobotanical histories of any medicinal plant.
* **Overall assessment of evidence:** Cinchona represents one of the clearest examples of a traditional medicinal plant whose effectiveness has been conclusively validated by modern science. The antimalarial activity of quinine is historically and scientifically unquestioned. However, the potency of its alkaloids means that cinchona occupies a position closer to pharmaceutical medicine than to routine herbal self-care. Modern use should emphasize its historical significance, bitter tonic properties, and role as the natural source of quinine rather than unsupervised medicinal administration.
Educational Use Only: The information presented on this page is provided for educational, historical, and informational purposes only. ArdNemeton na Tuatha and Bhùth Draoi do not provide medical advice. Always consult your physician and pharmacist before using any herb, mushroom, supplement, or botanical product for medicinal purposes. Traditional uses described herein do not constitute medical claims.